Table 1.
Member | ING expression | Progression implication | Study type | Cancer type | Reference |
---|---|---|---|---|---|
ING1 | Low | Lymph node metastasis | In vivo | Breast | [36] |
Low | Tumor progression | In vivo | Melanoma | [38] | |
Low | Distant metastasis | In vivo | Stomach | [23] | |
High | Lymph node metastasis | In vivo | OSCC | [39] | |
ING2 | Low | Metastasis | In vivo | Melanoma | [48] |
High | Invasion | In vitro | Colorectal | [46] | |
ING3 | Low | Metastasis | In vivo | Melanoma | [55] |
Low | TNM stage | In vivo | HNSCC | [72] | |
ING4 | Low | NF-κB activity | In vitro/in vivo | Glioma | [89] |
Low | HIF-1 activity | In vitro | Cervical | [87] | |
Low | HIF-1 activity | In vitro | Myeloma | [88] | |
Low | Migration | In vitro | Colon | [95] | |
Low | Metastasis | In vivo | Melanoma | [76] | |
High | p53 Activity | In vitro | Colon | [93] | |
High | Metastasis | In vitro | Breast | [83] | |
High | Migration | In vitro | Colon | [95] | |
High | Invasion, migration | In vitro | Melanoma | [76] | |
High | Invasion | In vitro | Glioma | [90] | |
High | Invasion | In vitro | Lung | [79] | |
ING5 | High | p53 Activity | In vitro | Colon | [93] |
OSCC oral squamous cell carcinoma, HNSCC head and neck squamous cell carcinoma